BK channel properties correlate with neurobehavioral severity in three -linked channelopathy mouse models.
AuthorPark, Su Mi
Roache, Cooper E
Iffland, Philip H
Moldenhauer, Hans J
Matychak, Katia K
Plante, Amber E
Lieberman, Abby G
Crino, Peter B
PublishereLife Sciences Publications
MetadataShow full item record
AbstractKCNMA1 forms the pore of BK K+ channels, which regulate neuronal and muscle excitability. Recently, genetic screening identified heterozygous KCNMA1 variants in a subset of patients with debilitating paroxysmal non-kinesigenic dyskinesia, presenting with or without epilepsy (PNKD3). However, the relevance of KCNMA1 mutations and the basis for clinical heterogeneity in PNKD3 has not been established. Here, we evaluate the relative severity of three KCNMA1 patient variants in BK channels, neurons, and mice. In heterologous cells, BKN999S and BKD434G channels displayed gain-of-function (GOF) properties, whereas BKH444Q channels showed loss-of-function (LOF) properties. The relative degree of channel activity was BKN999S > BKD434G>WT > BKH444Q. BK currents and action potential firing were increased, and seizure thresholds decreased, in Kcnma1N999S/WT and Kcnma1D434G/WT transgenic mice but not Kcnma1H444Q/WT mice. In a novel behavioral test for paroxysmal dyskinesia, the more severely affected Kcnma1N999S/WT mice became immobile after stress. This was abrogated by acute dextroamphetamine treatment, consistent with PNKD3-affected individuals. Homozygous Kcnma1D434G/D434G mice showed similar immobility, but in contrast, homozygous Kcnma1H444Q/H444Q mice displayed hyperkinetic behavior. These data establish the relative pathogenic potential of patient alleles as N999S>D434G>H444Q and validate Kcnma1N999S/WT mice as a model for PNKD3 with increased seizure propensity.
Data AvailibilityAll data generated and analyzed during this study are included in the manuscript, or provided as source data files. Python code is provided as Source Code File 1.
Data / Code Locationhttps://cdn.elifesciences.org/articles/77953/elife-77953-code1-v1.zip
Rights/Terms© 2022, Park et al.
calcium-activated potassium channel
paroxysmal non-kinesigenic dyskinesia
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19387
- Comparative gain-of-function effects of the KCNMA1-N999S mutation on human BK channel properties.
- Authors: Moldenhauer HJ, Matychak KK, Meredith AL
- Issue date: 2020 Feb 1
- KCNMA1-linked channelopathy.
- Authors: Bailey CS, Moldenhauer HJ, Park SM, Keros S, Meredith AL
- Issue date: 2019 Oct 7
- An emerging spectrum of variants and clinical features in KCNMA1-linked channelopathy.
- Authors: Miller JP, Moldenhauer HJ, Keros S, Meredith AL
- Issue date: 2021 Dec
- Lisdexamfetamine Therapy in Paroxysmal Non-kinesigenic Dyskinesia Associated with the KCNMA1-N999S Variant.
- Authors: Keros S, Heim J, Hakami W, Zohar-Dayan E, Ben-Zeev B, Grinspan Z, Kruer MC, Meredith AL
- Issue date: 2022 Feb
- Neuronal mechanism of a BK channelopathy in absence epilepsy and dyskinesia.
- Authors: Dong P, Zhang Y, Hunanyan AS, Mikati MA, Cui J, Yang H
- Issue date: 2022 Mar 22